447433-47-8

Upstream product

• 54802-10-7 3-aminobenzofuran-2-carboxamide 
• 611-20-1 salicylonitrile 
• 898373-46-1 3-(4-(trifluoromethyl)benzamido)benzofuran-2-carboxamide 
• 54802-12-9 2-(2-cyanophenoxy)acetamide 
• 329-15-7 4-trifluoromethyl-phenyl acetyl chloride 

Downstream Products

• 1275620-42-2 {4-cyclopropanesulfonylaminocarbonyl-2,15-dioxo-18-[2-(4-trifluoromethyl-phenyl)-benzo[4,5]furo[3,2-d]pyrimidin-4-yloxy]-3,16-diaza-tricyclo[14.3.0.0(4,6)]nonadec-7-en-14-yl}-carbamic acid cyclopentyl ester 
• 1195977-16-2 4-chloro-2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidine 
• 1195977-17-3 C₂₈H₂₆F₃N₃O₆ 
• 1195977-18-4 C₂₃H₁₈F₃N₃O₄ 
• 1195977-22-0 C₄₆H₅₁F₃N₆O₉S 
• 1275620-40-0 C₃₈H₄₁F₃N₄O₇ 
• 1275620-41-1 C₃₇H₃₉F₃N₄O₇ 
• 1275617-56-5 {4-cyclopropanesulfonylaminocarbonyl-2,15-dioxo-18-[2-(4-trifluoromethyl-phenyl)-benzo[4,5]furo[3,2-d]pyrimidin-4-yloxy]-3,16-diaza-tricyclo[14.3.0.0(4,6)]nonadec-14-yl}-carbamic acid cyclopentyl ester 
• 1315326-69-2 (2S,4R)-1-(tert-butoxycarbonyl)-4-(2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)pyrrolidine-2-carboxylic acid 
• 1315325-52-0 (2R,6S,13aS,14aR,16aS,Z)-N-(cyclo-propylsulfonyl)-6-(4,5-dimethylthiazol-2-ylamino)-5,16-dioxo-2-(2-(4-(trifluoromethyl-)phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide 
• 1315326-96-5 (2R,6S,13aS,14aR,16aS,Z)-N-(cyclopropylsulfonyl)-5,16-dioxo-6-thioureido-2-(2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide 
• 1315326-95-4 (2R,6S,13aS,14aR,16aS,Z)-6-amino-N-(cyclopropylsulfonyl)-5,16-dioxo-2-(2-(4-(trifluoromethyl)phenyl)-benzofuro[3,2-d]pyrimidin-4-yloxy)-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrol-e[1,2-a][1,4]diazacyclopentadecine-14a-carboxamide hydrochloride 
• 1195976-53-4 C₄₃H₄₇F₃N₆O₉S 
• 1315324-53-8 methyl 2-((2S)-1-((2S,4R)-2-((2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropyl-carbamoyl)-4-(2-(4-(trifluoromethyl)phenyl)benzofuro[3,2-d]pyrimidin-4-yloxy-)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-ylamino)thiazole-4-carboxylate 

Relevant academic research and scientific papers

HCV PROTEASE INHIBITORS

This invention relates to compounds of Formula (I), (II), or (III) shown in the specification. These compounds can be used to treat hepatitis C virus infection.

HCV PROTEASE INHIBITORS

This invention relates to macrocyclic compounds of formula (I) shown in the specification. These compounds can be used to treat hepatitis C virus infection.

HCV PROTEASE INHIBITORS

This invention relates to macrocyclic compounds shown in the specification. These compounds can be used to treat hepatitis C virus infection.